
|Articles|August 25, 2017
Aseptic Fill/Finish Line for Drug Product Manufacturing
Author(s)BioPharm International Editors
Ajinomoto Althea’s Optima VFVM 7000 aseptic fill/finish line supports a range of drug substance APIs.
Advertisement
Ajinomoto Althea’s Optima VFVM 7000 aseptic fill/finish line supports a range of drug substance APIs compatible with both peristaltic and rotary piston pump filling systems. The fill/finish line enables large batch sizes and a range of filling volumes (0.2–100 mL) while reducing product loss. According to the company, the equipment also provides total in-process-control, nitrogen purging, and several additional features to maximize yield.
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Next-Generation Modalities Drive New Antibody Discovery
2
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
3
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
4
European Approval of Donidalorsen Expands RNA-Targeted Prevention Strategies for HAE
5




